Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma

Signal Transduct Target Ther. 2020 Aug 11;5(1):149. doi: 10.1038/s41392-020-00267-8.

Authors

Ruining Gong¹, He Ren²

Affiliations

¹ Department of Gastroenterology, Center of Tumor Immunology and Cytotherapy, Medical Research Center of The Affiliated Hospital of Qingdao University, 266003, Qingdao, China.
² Department of Gastroenterology, Center of Tumor Immunology and Cytotherapy, Medical Research Center of The Affiliated Hospital of Qingdao University, 266003, Qingdao, China. herenrh@163.com.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Chemokines
Humans
Immunotherapy
Pancreatic Neoplasms* / drug therapy
Peptides
Receptors, Chemokine*

Substances

4-fluorobenzoyl-TN-14003
Antibodies, Monoclonal, Humanized
Chemokines
Peptides
Receptors, Chemokine
pembrolizumab